• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Cyclo Therapeutics Inc (NQ: CYTH )

    0.7164 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Cyclo Therapeutics Inc

    < Previous 1 2 3 4 5 6 Next >
    Cyclo Therapeutics Recognizes Niemann-Pick Disease Awareness Month Highlighting Need for Broader Awareness and Support for Research to Find a Treatment
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Announces Abstract Accepted for Poster Presentation at the 14th International Congress of Inborn Errors of Metabolism (ICIEM)
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics to Participate in the 2021 Virtual Cyclodextrin Conference Hosted by CycloLab
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Appoints Lise Lund Kjems, MD, PhD as Chief Medical Officer
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics' Trappsol Shows Early Safety, Efficacy In Genetic Disorder
    Cyclo Therapeutics Inc (NASDAQ: CYTH) has announced new data from its Phase 1 extension study evaluating Trappsol Cyclo Niemann-Pick Disease Type C1 (NPC), a... 
    Via Benzinga
    Cyclo Therapeutics Announces New Positive Safety and Efficacy Data from Ongoing Phase 1 Open-Label Extension Study of Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Commences Commercial-Scale Manufacturing for Trappsol® Cyclo™
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Gainers vTv Therapeutics (NASDAQ:VTVT) shares rose 30.08% to $3.07 during Tuesday's pre-market session. The company's market cap stands at $251.7 million. Adial... 
    Via Benzinga
    Cyclo Therapeutics to Present at the 2021 NPC Patient and Family Conference Hosted by the Australian NPC Disease Foundation
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Shares Move Higher On Kickstart Of Late-Stage NPC Trial With Trappsol Cyclo
    Cyclo Therapeutics Inc (NASDAQ: CYTH) has commenced its pivotal Phase 3 study (TransportNPC) evaluating Trappsol Cyclo for Niemann-Pick Disease Type C1 (NPC1). The... 
    Via Benzinga
    Cyclo Therapeutics Commences Patient Enrollment in TransportNPC, a Pivotal Phase 3 Study Evaluating Trappsol® Cyclo™ in Niemann-Pick Type C1
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Announces Launch of New Website
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Gainers RAPT Therapeutics (NASDAQ:RAPT) s... 
    Via Benzinga
    Cyclo Therapeutics Announces Inclusion in the Russell 2000® Index
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics to Present at the JMP Securities Life Sciences Conference
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Gainers Strongbridge Biopharma (NASDAQ:SBBP) stock moved upwards by 14.1% to $2.75 during Monday's pre-market session. The market value of their outstanding shares is... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Gainers Gracell Biotechnologies (NASDAQ:GRCL) shares rose 21.25% to $17.69 during Friday's regular session. Trading volume for Gracell Biotechnologies's stock is... 
    Via Benzinga
    Cyclo Therapeutics to Participate in the M-Vest Virtual Conference Series: Alzheimer’s Disease Panel
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Appoints Lori McKenna Gorski as Global Head of Patient Advocacy
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    Cyclo Therapeutics Announces Design of Pivotal Phase 3 Study Evaluating Trappsol® Cyclo™ in Niemann-Pick Type C1
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    55 Biggest Movers From Friday
    Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) jumped 45.5% to close at $49.80 on Friday after dropping around 22% on Thursday. Brooklyn ImmunoTherapeutics acquired... 
    Via Benzinga
    Cyclo Therapeutics to Proceed with IND Filing for Phase 2 Trial Using Intravenous Trappsol® Cyclo™ in Alzheimer’s Disease
    From Cyclo Therapeutics, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Gainers Intec Pharma (NASDAQ:NTEC) shares increased by 7.67% to $4.35 during Monday's after-market session. Intec Pharma's trading volume hit 412 shares by close,... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.